Xiaofang Wang
Shihezi University(CN)Shenyang Pharmaceutical University(CN)Liaoning University(CN)Nebraska Medical Center(US)Mayo Clinic(US)Northeast Agricultural University(CN)Chinese Academy of Sciences(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking Union Medical College Hospital(CN)WinnMed(US)Mayo Clinic in Arizona(US)Shanghai Institute of Technical Physics(CN)Xi'an Institute of Optics and Precision Mechanics(CN)Institute of Hematology & Blood Diseases Hospital(CN)Shanghai Dianji University(CN)University of Chinese Academy of Sciences(CN)Chengdu University of Traditional Chinese Medicine(CN)University of Nebraska Medical Center(US)Texas A&M University(US)University of Science and Technology Beijing(CN)
Publications by Year
Research Areas
Bone and Dental Protein Studies, Genetic and Kidney Cyst Diseases, dental development and anomalies, Biomedical Research and Pathophysiology, Oral and Maxillofacial Pathology
Most-Cited Works
- → The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein(2002)760 cited
- → Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist(2003)667 cited
- → Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease(2004)480 cited
- → Effectiveness of Vasopressin V2 Receptor Antagonists OPC-31260 and OPC-41061 on Polycystic Kidney Disease Development in the PCK Rat(2005)332 cited
- → Active Computerized Pharmacovigilance Using Natural Language Processing, Statistics, and Electronic Health Records: A Feasibility Study(2009)288 cited
- → Vasopressin Directly Regulates Cyst Growth in Polycystic Kidney Disease(2007)278 cited